当前位置:公众访问 >页面
简体中文 / English
1.Screening
1.1.Inclusion Criteria

Eligible participant has to fullfill all of the following items

/
/
/
/
/
/
/

1.2.Exclusion Criteria

Anyone with one of following items or more should be excluded:

/
/
/
/
/
/
/
/
/
/

2.Baseline
2.1.General information

Date of signing the informed consent

2024-1-31

Date of birth

2011-09-15 yyyy-mm-dd

Age

12 Years

Education background

Primary school

Occupation

Other

Other (Description)

学生

2.2.Medical history

1天加重3小时 小时

Number of pregnancy

0

Number of delivery

0

If has delivery history, select following items

partus maturus

--

premature delivery

--

abortion

--

Last pregnancy

-- yyyy-mm-dd

Average times of menstrual onset a year

12 次/年

Average menstrual cycle

6.5 天(days)

Menarche time

11 岁(years)

The time of last Menstruation

2023-12-31 年、月、日(yyyy-mm-dd)

The time of menstrual onset before the last one

不详 年、月、日(yyyy-mm-dd)

-- 年/月/日(yyyy-mm-dd)

Namy of the drug to be allergied

--

2.3.Physical examination

Vulva

Normal

Description in detail for abnormal

--

Vagina

Not examined

Description in detail for abnormal

--

Uterine neck

Not examined

Description in detail for abnormal

--

Corpus uteri

Not examined

Description in detail for abnormal

--

Adnexa uteri

Left side

Not examined

Description in detail for abnormal

--

Right side

Not examined

Description in detail for abnormal

--

Weight

57 kg

Hight

1600 mm

Systolic pressure (SP)

92 mmHg

Diastolic pressure

63 mmHg

Temperature

36.3 degree Celsius

Pulse rate

104 次/分

Breath frequency

23 次/分

Doctor signature

刘义彬

Date

2024-1-31 yyyy-mm-dd

2.4.Blood Routine Tests

WBC

6.80 ×109 /L

NEUT%

76.99 %

LY%

10.97 %

MONO%

11.36

RBC

4.68 ×10^12 /L

HGB

130 g/L

PLT

323 ×10^9 /L

Researcher signature

刘义彬

Date

2024-1-31 yyyy-mm-dd

2.5.Urine Routine Test

Acidity and allkalinity

pH value

--

Urine protein

Urine red cell

Urine WBC

Urine glucos

Urine Bilirubin

Urine HCG

KET

SG

--

UBG

NIT

Date of test

-- yyyy-mm-dd

2.6.Blood Electrolytes Tests

Date of test

2024-1-31 yyyy-mm-dd

K

4.04 mmol/L

Na

139.3 mmol/L

Cl

103.2 mmol/L

Ca

2.40 mmol/L

P

1.35 mmol/L

2.7.Coagulation Function Tests

Date of examination

2024-1-31 yyyy-mm-dd

Prothrombin time

12.9

Thrombin time (TT)

13.8

Activated partial thromboplastin time (APTT)

28.0

Fibrinogen (FIB)

3.38 g/L

2.8.Serum Liver Function Tests

ALT

17.2 IU/L

AST

16.7 IU/L

GGT

6.0 U/L

Serum bilirubin

11.80 μmol/L

Indirect bilirubin

7.60 umol/L

Direct bilirubin

4.20 umol/L

Serum albumin

44.2 g/L

Serum globulin

30.5 g/L

Serum total protein

74.7 g/L

Date of test

2024-1-31 yyyy-mm-dd

2.9.HBV/HCV/HIV/Syphilis Markers Test
2.2.9.2.9.1、HBV Markers Test

Negative

Date of test

2024-1-31 yyyy-mm-dd

2.2.9.2.9.2、HCV Marker Test

Negative

Date of test

2024-1-31 yyyy-mm-dd

2.2.9.2.9.3、HIV Marker Test

Negative

Date of test

2024-1-31 yyyy-mm-dd

2.2.9.2.9.4、Syphilis Marker Test

Negative

Date of test

2024-1-31 yyyy-mm-dd

2.10.Renel Function Test

SCr

53.0 μmol/L

Blood urea

4.30 mmol/L

Blood uric acid

319.0 μmol/L

Date of test

2024-1-31 yyyy-mm-dd

2.11.D-dimer

D-dimer value

0.13 ug/mL

Date of test

2024-1-31

2.12.hCG Test

Urine pregnancy test

Not tested

Blood HCG concentration

-- mIU/mL

Date of test

-- yyyy-mm-dd

2.13.Image Examinations
2.2.13.2.13.1、Ultrasound

Size of the ulcer

5.13*4.71*4.06 cm*cm

Uterine echo distribution

Even

Endometrial thickness

12.1 mm

Left ovary size

3.52*1.92 cm ×cm

Shape of Left ovary

Normal

Size of the Ovarian cyst

--

Right ovary size

3.52*2.48 cm ×cm

Shape of right ovary

Ovarian cyst

Size of Ovarian cyst

7.78*8.59*6.26cm

Description of other abnormal findings

--

Diagnosis of the Ultrasound B

卵巢囊肿蒂扭转

Doctor signature

刘义彬

Date of examination

2024-1-31 yyyy-mm-dd

2.2.13.2.13.2、Other examination
2.14.Visual Analogue Scale

Pain Visual Analogue Score

Very pain

2.15.Blood Gas Analysis

PH

未查

PCO2

未查 mmHg

P02

未查 mmHg

SO2

未查

HCO3

未查 mmol/l

SBE

未查 mmol/l

LAC

未查 mmol/L

Date of examination

-- (yyyy-mm-dd)

3.In the process of the treatment
3.1.Treatment Record

右卵巢

7*6*5 cm

逆时针360° °

/

刘义彬

2024-1-31

4.Follow-up
4.1.D-dimer

D-dimer value

0.16 ug/mL

Date of test

2024-2-1

4.2.Physical examination

Body temperature

37

Systolic pressure (SP)

92 mmHg

Diastolic pressure (DP)

63 mmHg

Heart Rate, HR

82 次/分

Pulse

82 次/秒

4.3.Blood Routine Tests

WBC

5.2 ×109 /L

NEUT%

78.68 %

LY%

9.19 %

MONO%

11.95

RBC

4.05 ×10^12 /L

HGB

114 g/L

PLT

247 ×10^9 /L

Date

2024-2-1 yyyy-mm-dd

4.4.Visual Analogue Scale

/

Pain Visual Analogue Score

Occasionally very slight pain

5.Speciman management system

sample collection

Collected

Volume

1 ml

Time of collection

2024-1-24/2024-2-1 yyyy-mm-dd-hh-min.

Label Number of the sample

2561848

6.ADR/ADE management system

Date received at DCC

-- yyyymmdd

Report type

Name of this event

--

SAE start date

-- yyyymmdd

SAE stop date

-- yyyymmdd

Was this an unanticipated adverse event

Attribution to Study Drug

Outcome Type(check all that apply)

Recovery Description: (check only one)

Please provide a brief narrative of the SAE occurrence below

--

Name of the recorder

--

Data

-- yyyymmdd

Site Investigator’s signature

--

Data

-- yyyymmdd